Trial Profile
Diagnostic use of 99mTecnetium labeled infliximab in Crohn's disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2014
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 25 Aug 2014 New trial record